No pre-market FDA approval is required to sell a kojic acid and tranexamic acid soap in the United States, provided the product is positioned and labeled as a cosmetic — not a drug. This is an important distinction because the claims you make on the label and in marketing materials determine whether the FDA classifies your product as a cosmetic (low regulatory burden) or an OTC drug (significant regulatory burden, including pre-market safety and efficacy substantiation).
As a cosmetic, your brightening soap must comply with FDA's cosmetic regulations under the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). MoCRA introduced new requirements that are now being phased in: mandatory facility registration for manufacturers (domestic and foreign), product listing with FDA, serious adverse event reporting, and safety substantiation records. These are not pre-market approval requirements, but they are compliance obligations that founders often overlook.
The critical claims boundary: you can say a product "brightens skin," "improves the appearance of uneven skin tone," or "reduces the look of dark spots" — these are cosmetic claims about appearance. You cannot say it "treats melasma," "corrects hyperpigmentation," or "inhibits melanin production" — these cross into disease or physiological claims that trigger drug classification. The phrase "clinically proven to reduce dark spots" is a gray area that the FDA has scrutinized; if you use it, have the clinical data to back it up.
For ingredient safety, both kojic acid and tranexamic acid are used globally in cosmetics with established safety profiles at standard cosmetic concentrations. There is no FDA-mandated pre-approval for cosmetic ingredients. However, you as the brand owner are legally responsible for ensuring your product is safe before it goes to market. This means your manufacturer should have a safety assessment and stability data on file for the formula.
If you sell in California, Proposition 65 is relevant — kojic acid is not currently on the Prop 65 list, but it pays to check current listings before launch since the list is updated periodically.
If you plan to export to the EU, registration via the Cosmetic Products Notification Portal (CPNP) and appointment of an EU Responsible Person are required before sale. AJ Cosmo Labs can connect you with manufacturers experienced in multi-market compliance.
Ingredients in this answer: Tranexamic Acid · Kojic Acid
Read the full guide on Private Label Kojic Acid & Tranexamic Acid Soap Manufacturer Low MOQ →